How do the dolutegravir and lamivudine components of Dovato inhibit HIV replication?

In Dovato, dolutegravir binds HIV integrase’s active site and blocks strand transfer during viral DNA integration, while lamivudine’s active triphosphate metabolite inhibits HIV-1 and HIV-2 reverse transcriptase through incorporation of its monophosphate form into viral DNA, causing chain termination.